Komiya I, Murata S, Umemura K, Tomono N, Kikai S, Fujita M
J Pharmacobiodyn. 1981 May;4(5):362-73. doi: 10.1248/bpb1978.4.362.
The behaviors of dibekacin after three administration methods to rabbits and dogs were pharmacokinetically analysed. 1) In both rabbits and dogs, the pharmacokinetic constants for the intravenous constant infusion and intramuscular injection were similar to each other, and the serum levels after the intravenous constant infusion for 1 hr were similar to those after the intramuscular injection except the peak time. 2) In both rabbits and dogs, Vd increased with the dose and a linear correlation was noted between log Vd and log (dose). 3) The tissue concentrations of dibekacin decreased with the decrease in the serum concentration. 4) A correlation equation, log T 1/2 = 0.194 . log B + 1.128, was obtained, where T 1/2 and B represent the biological half-life of dibekacin and the body weight of animals, respectively. It was suggested that the pharmacokinetic behaviors of dibekacin in human beings can be predicted from the results of the animal experiments.
对兔和犬采用三种给药方法后地贝卡星的行为进行了药代动力学分析。1)在兔和犬中,静脉恒速输注和肌内注射的药代动力学常数彼此相似,静脉恒速输注1小时后的血清水平除达峰时间外与肌内注射后的相似。2)在兔和犬中,表观分布容积随剂量增加,且log Vd与log(剂量)之间存在线性相关性。3)地贝卡星的组织浓度随血清浓度降低而降低。4)得到一个相关方程,log T 1/2 = 0.194·log B + 1.128,其中T 1/2和B分别代表地贝卡星的生物半衰期和动物体重。提示可根据动物实验结果预测地贝卡星在人体内的药代动力学行为。